Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Lymphoid 2Gynecologic 2Gastrointestinal 2Breast 2Thoracic 1Plasma cell 1Other 1Head & Neck 1

Conditions

Pain, Postoperative 1Pain 1Multiple Myeloma 1Lymphoma 1

Interventions

Dexamethasone 882Bortezomib 481Lenalidomide 467Cyclophosphamide 367Melphalan 276Calcium Dobesilate 265daratumumab 241pomalidomide 216carfilzomib 188fludarabine phosphate 141fludarabine 137Thalidomide 125Peripheral Blood Stem Cell Transplantation 120Filgrastim 115ixazomib 94Mycophenolic Acid 91Granulocyte Colony-Stimulating Factor 90Busulfan 89Whole-Body Irradiation 88dexamethasone acetate 87Tacrolimus 79dexamethasone 21-phosphate 74isatuximab 70Cyclosporine 68auricularum 67Prednisone 67elotuzumab 63belantamab mafodotin 60Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ketorolac Tromethamine × Plasma cell × Clear all
NCT03823534 2026-04-22

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

St. Louis University

Phase 3 Recruiting
60 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡